Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Knight Therapeutics Inc.
DescriptionSelective nNOS inhibitor
Molecular Target Neuronal nitric oxide synthase 1 (NOS1) (nNOS) ; Norepinephrine transporter
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMigraine
Indication DetailsPrevent migraine
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today